China Multiplex Biomarker Imaging Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Multiplex Biomarker Imaging industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ToposNomos Ltd

    • Abcam Plc

    • Aushon BioSystems Ltd

    • Illumina Inc

    • Merck KGaA

    • US Biomax Inc

    • Bio-Rad Laboratories, Inc

    • MicroConstants, Inc

    • Ventana Medical Systems, Inc

    • Thermo Fisher Scientific

    By Type:

    • Tissue Microarray (TMA) Assay

    • Fluorescent in the Situ Hybridization (FISH) Assay

    • Immunohistochemistry (IHC) Assay

    • Toponome Imaging System (TIS)

    • Immuno Fluorescence (IF) Assay

    By Application:

    • Oncology Studies

    • Drug Safety

    • Genetic Characterization Studies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Multiplex Biomarker Imaging Market Overview 2018-2029

    • 1.1 China Multiplex Biomarker Imaging Industry Development Overview

    • 1.2 China Multiplex Biomarker Imaging Industry Development History

    • 1.3 China Multiplex Biomarker Imaging Industry Market Size (2018-2029)

    • 1.4 China Multiplex Biomarker Imaging Market Analysis by Type from Production Side

      • 1.4.1 China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Tissue Microarray (TMA) Assay (2018-2029)

      • 1.4.2 China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Fluorescent in the Situ Hybridization (FISH) Assay (2018-2029)

      • 1.4.3 China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Immunohistochemistry (IHC) Assay (2018-2029)

      • 1.4.4 China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Toponome Imaging System (TIS) (2018-2029)

      • 1.4.5 China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Immuno Fluorescence (IF) Assay (2018-2029)

    • 1.5 China Multiplex Biomarker Imaging Market Analysis by Application from Consumption End

      • 1.5.1 China Multiplex Biomarker Imaging Sales Volume, Sales Value and Growth Rate of Oncology Studies (2018-2029)

      • 1.5.2 China Multiplex Biomarker Imaging Sales Volume, Sales Value and Growth Rate of Drug Safety (2018-2029)

      • 1.5.3 China Multiplex Biomarker Imaging Sales Volume, Sales Value and Growth Rate of Genetic Characterization Studies (2018-2029)

    • 1.6 China Multiplex Biomarker Imaging Market Analysis by Region

      • 1.6.1 North China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    Chapter 2 China Multiplex Biomarker Imaging Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Multiplex Biomarker Imaging Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Multiplex Biomarker Imaging Market Status and Competition Analysis in 2023

      • 2.2.3 China Multiplex Biomarker Imaging Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Multiplex Biomarker Imaging Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Multiplex Biomarker Imaging Industry Development

    Chapter 3 Multiplex Biomarker ImagingIndustry Chain Analysis

    • 3.1 Multiplex Biomarker Imaging Industry Chain

    • 3.2 Multiplex Biomarker Imaging Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Multiplex Biomarker Imaging Market

    • 3.3 Multiplex Biomarker Imaging Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Multiplex Biomarker Imaging Market

    Chapter 4 China Multiplex Biomarker Imaging Market, by Type

    • 4.1 China Multiplex Biomarker Imaging Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Multiplex Biomarker Imaging Total Production Volume and Growth Rate from Production Side

    • 4.5 China Multiplex Biomarker Imaging Production Volume and Growth Rate, by Type

      • 4.5.1 China Multiplex Biomarker Imaging Production Volume and Growth Rate of Tissue Microarray (TMA) Assay

      • 4.5.2 China Multiplex Biomarker Imaging Production Volume and Growth Rate of Fluorescent in the Situ Hybridization (FISH) Assay

      • 4.5.3 China Multiplex Biomarker Imaging Production Volume and Growth Rate of Immunohistochemistry (IHC) Assay

      • 4.5.4 China Multiplex Biomarker Imaging Production Volume and Growth Rate of Toponome Imaging System (TIS)

      • 4.5.5 China Multiplex Biomarker Imaging Production Volume and Growth Rate of Immuno Fluorescence (IF) Assay

    Chapter 5 China Multiplex Biomarker Imaging Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Multiplex Biomarker Imaging Total Market Size and Growth Rate from Consumption End

    • 5.5 China Multiplex Biomarker Imaging Market Size and Growth Rate, by Application

      • 5.5.1 China Multiplex Biomarker Imaging Market Size and Growth Rate of Oncology Studies

      • 5.5.2 China Multiplex Biomarker Imaging Market Size and Growth Rate of Drug Safety

      • 5.5.3 China Multiplex Biomarker Imaging Market Size and Growth Rate of Genetic Characterization Studies

    Chapter 6 China Multiplex Biomarker Imaging Market, by Region

    • 6.1 China Multiplex Biomarker Imaging Production Volume and Production Value, by Region

    • 6.2 China Multiplex Biomarker Imaging Sales Volume and Sales Value, by Region

    Chapter 7 North China Multiplex Biomarker Imaging Market Analysis

    • 7.1 North China Multiplex Biomarker Imaging Market, by Type

    • 7.2 North China Multiplex Biomarker Imaging Market, by Application

    Chapter 8 Central China Multiplex Biomarker Imaging Market Analysis

    • 8.1 Central China Multiplex Biomarker Imaging Market, by Type

    • 8.2 Central China Multiplex Biomarker Imaging Market, by Application

    Chapter 9 South China Multiplex Biomarker Imaging Market Analysis

    • 9.1 South China Multiplex Biomarker Imaging Market, by Type

    • 9.2 South China Multiplex Biomarker Imaging Market, by Application

    Chapter 10 East China Multiplex Biomarker Imaging Market Analysis

    • 10.1 East China Multiplex Biomarker Imaging Market, by Type

    • 10.2 East China Multiplex Biomarker Imaging Market, by Application

    Chapter 11 Northeast China Multiplex Biomarker Imaging Market Analysis

    • 11.1 Northeast China Multiplex Biomarker Imaging Market, by Type

    • 11.2 Northeast China Multiplex Biomarker Imaging Market, by Application

    Chapter 12 Southwest China Multiplex Biomarker Imaging Market Analysis

    • 12.1 Southwest China Multiplex Biomarker Imaging Market, by Type

    • 12.2 Southwest China Multiplex Biomarker Imaging Market, by Application

    Chapter 13 Northwest China Multiplex Biomarker Imaging Market Analysis

    • 13.1 Northwest China Multiplex Biomarker Imaging Market, by Type

    • 13.2 Northwest China Multiplex Biomarker Imaging Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ToposNomos Ltd

        • 14.1.1 ToposNomos Ltd Company Profile

        • 14.1.2 ToposNomos Ltd Multiplex Biomarker Imaging Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Abcam Plc

        • 14.2.1 Abcam Plc Company Profile

        • 14.2.2 Abcam Plc Multiplex Biomarker Imaging Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Aushon BioSystems Ltd

        • 14.3.1 Aushon BioSystems Ltd Company Profile

        • 14.3.2 Aushon BioSystems Ltd Multiplex Biomarker Imaging Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Illumina Inc

        • 14.4.1 Illumina Inc Company Profile

        • 14.4.2 Illumina Inc Multiplex Biomarker Imaging Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Merck KGaA

        • 14.5.1 Merck KGaA Company Profile

        • 14.5.2 Merck KGaA Multiplex Biomarker Imaging Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 US Biomax Inc

        • 14.6.1 US Biomax Inc Company Profile

        • 14.6.2 US Biomax Inc Multiplex Biomarker Imaging Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Bio-Rad Laboratories, Inc

        • 14.7.1 Bio-Rad Laboratories, Inc Company Profile

        • 14.7.2 Bio-Rad Laboratories, Inc Multiplex Biomarker Imaging Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 MicroConstants, Inc

        • 14.8.1 MicroConstants, Inc Company Profile

        • 14.8.2 MicroConstants, Inc Multiplex Biomarker Imaging Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Ventana Medical Systems, Inc

        • 14.9.1 Ventana Medical Systems, Inc Company Profile

        • 14.9.2 Ventana Medical Systems, Inc Multiplex Biomarker Imaging Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Thermo Fisher Scientific

        • 14.10.1 Thermo Fisher Scientific Company Profile

        • 14.10.2 Thermo Fisher Scientific Multiplex Biomarker Imaging Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Multiplex Biomarker Imaging Industry Research Conclusions

    • 15.2 Multiplex Biomarker Imaging Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Multiplex Biomarker Imaging Industry Market Size (2018-2029)

    • Figure China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Tissue Microarray (TMA) Assay (2018-2029)

    • Figure China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Fluorescent in the Situ Hybridization (FISH) Assay (2018-2029)

    • Figure China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Immunohistochemistry (IHC) Assay (2018-2029)

    • Figure China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Toponome Imaging System (TIS) (2018-2029)

    • Figure China Multiplex Biomarker Imaging Production Volume, Production Value and Growth Rate of Immuno Fluorescence (IF) Assay (2018-2029)

    • Figure China Multiplex Biomarker Imaging Sales Volume, Sales Value and Growth Rate of Oncology Studies (2018-2029)

    • Figure China Multiplex Biomarker Imaging Sales Volume, Sales Value and Growth Rate of Drug Safety (2018-2029)

    • Figure China Multiplex Biomarker Imaging Sales Volume, Sales Value and Growth Rate of Genetic Characterization Studies (2018-2029)

    • Figure North China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    • Figure Central China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    • Figure South China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    • Figure East China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Multiplex Biomarker Imaging Market Size and Growth Rate from 2018-2029

    • Figure Multiplex Biomarker Imaging Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Multiplex Biomarker Imaging Market Share by Type in 2018

    • Figure China Multiplex Biomarker Imaging Market Share by Type in 2023

    • Figure China Multiplex Biomarker Imaging Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Multiplex Biomarker Imaging Production Volume and Growth Rate of Tissue Microarray (TMA) Assay (2018-2023)

    • Figure China Multiplex Biomarker Imaging Production Volume and Growth Rate of Fluorescent in the Situ Hybridization (FISH) Assay (2018-2023)

    • Figure China Multiplex Biomarker Imaging Production Volume and Growth Rate of Immunohistochemistry (IHC) Assay (2018-2023)

    • Figure China Multiplex Biomarker Imaging Production Volume and Growth Rate of Toponome Imaging System (TIS) (2018-2023)

    • Figure China Multiplex Biomarker Imaging Production Volume and Growth Rate of Immuno Fluorescence (IF) Assay (2018-2023)

    • Figure China Multiplex Biomarker Imaging Market Share by Application in 2018

    • Figure China Multiplex Biomarker Imaging Market Share by Application in 2023

    • Figure China Multiplex Biomarker Imaging Total Market Size and Growth Rate from Consumption End

    • Figure China Multiplex Biomarker Imaging Market Size and Growth Rate of Oncology Studies (2018-2023)

    • Figure China Multiplex Biomarker Imaging Market Size and Growth Rate of Drug Safety (2018-2023)

    • Figure China Multiplex Biomarker Imaging Market Size and Growth Rate of Genetic Characterization Studies (2018-2023)

    • Table China Multiplex Biomarker Imaging Production Volume by Region (2018-2023)

    • Table China Multiplex Biomarker Imaging Production Volume Share by Region (2018-2023)

    • Figure China Multiplex Biomarker Imaging Production Volume Share by Region (2018-2023)

    • Table China Multiplex Biomarker Imaging Production Value by Region (2018-2023)

    • Table China Multiplex Biomarker Imaging Production Value Share by Region (2018-2023)

    • Figure China Multiplex Biomarker Imaging Production Value Share by Region (2018-2023)

    • Table China Multiplex Biomarker Imaging Sales Volume by Region (2018-2023)

    • Table China Multiplex Biomarker Imaging Sales Volume Share by Region (2018-2023)

    • Figure China Multiplex Biomarker Imaging Sales Volume Share by Region (2018-2023)

    • Table China Multiplex Biomarker Imaging Sales Value by Region (2018-2023)

    • Table China Multiplex Biomarker Imaging Sales Value Share by Region (2018-2023)

    • Figure China Multiplex Biomarker Imaging Sales Value Share by Region (2018-2023)

    • Table North China Multiplex Biomarker Imaging Production Volume by Type (2018-2023)

    • Table North China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Figure North China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Table North China Multiplex Biomarker Imaging Sales Volume by Application (2018-2023)

    • Table North China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Figure North China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Table Central China Multiplex Biomarker Imaging Production Volume by Type (2018-2023)

    • Table Central China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Figure Central China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Table Central China Multiplex Biomarker Imaging Sales Volume by Application (2018-2023)

    • Table Central China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Figure Central China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Table South China Multiplex Biomarker Imaging Production Volume by Type (2018-2023)

    • Table South China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Figure South China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Table South China Multiplex Biomarker Imaging Sales Volume by Application (2018-2023)

    • Table South China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Figure South China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Table East China Multiplex Biomarker Imaging Production Volume by Type (2018-2023)

    • Table East China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Figure East China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Table East China Multiplex Biomarker Imaging Sales Volume by Application (2018-2023)

    • Table East China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Figure East China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Table Northeast China Multiplex Biomarker Imaging Production Volume by Type (2018-2023)

    • Table Northeast China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Figure Northeast China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Table Northeast China Multiplex Biomarker Imaging Sales Volume by Application (2018-2023)

    • Table Northeast China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Table Southwest China Multiplex Biomarker Imaging Production Volume by Type (2018-2023)

    • Table Southwest China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Figure Southwest China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Table Southwest China Multiplex Biomarker Imaging Sales Volume by Application (2018-2023)

    • Table Southwest China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Table Northwest China Multiplex Biomarker Imaging Production Volume by Type (2018-2023)

    • Table Northwest China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Figure Northwest China Multiplex Biomarker Imaging Production Volume Share by Type (2018-2023)

    • Table Northwest China Multiplex Biomarker Imaging Sales Volume by Application (2018-2023)

    • Table Northwest China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Multiplex Biomarker Imaging Sales Volume Share by Application (2018-2023)

    • Table ToposNomos Ltd Company Profile

    • Table ToposNomos Ltd Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table Abcam Plc Company Profile

    • Table Abcam Plc Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table Aushon BioSystems Ltd Company Profile

    • Table Aushon BioSystems Ltd Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table Illumina Inc Company Profile

    • Table Illumina Inc Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table Merck KGaA Company Profile

    • Table Merck KGaA Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table US Biomax Inc Company Profile

    • Table US Biomax Inc Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table Bio-Rad Laboratories, Inc Company Profile

    • Table Bio-Rad Laboratories, Inc Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table MicroConstants, Inc Company Profile

    • Table MicroConstants, Inc Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table Ventana Medical Systems, Inc Company Profile

    • Table Ventana Medical Systems, Inc Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Company Profile

    • Table Thermo Fisher Scientific Multiplex Biomarker Imaging Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.